Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-81,415
Closed -$19.7M 272
2022
Q1
$19.7M Sell
81,415
-3,184
-4% -$732K 0.17% 140
2021
Q4
$19M Sell
84,599
-2,604
-3% -$550K 0.16% 155
2021
Q3
$18.5M Sell
87,203
-3,627
-4% -$835K 0.17% 142
2021
Q2
$22.1M Sell
90,830
-67,645
-43% -$16.6M 0.21% 128
2021
Q1
$39.4M Sell
158,475
-67,256
-30% -$16M 0.29% 65
2020
Q4
$51.9M Buy
225,731
+45,152
+25% +$10.4M 0.36% 40
2020
Q3
$45.9M Sell
180,579
-28,987
-14% -$7.18M 0.31% 51
2020
Q2
$49.4M Sell
209,566
-24,227
-10% -$5.53M 0.39% 40
2020
Q1
$47.4M Sell
233,793
-23,328
-9% -$5.1M 0.44% 35
2019
Q4
$62M Buy
257,121
+68,849
+37% +$15.2M 0.43% 30
2019
Q3
$36.4M Sell
188,272
-35,060
-16% -$6.73M 0.22% 104
2019
Q2
$41.2M Sell
223,332
-76,854
-26% -$13.8M 0.28% 74
2019
Q1
$57M Sell
300,186
-6,702
-2% -$1.28M 0.41% 35
2018
Q4
$59.7M Buy
+306,888
New +$59.9M 0.48% 29
2018
Q3
Sell
-224,463
Closed -$41.4M 1122
2018
Q2
$41.4M Sell
224,463
-1,244
-0.6% -$220K 0.29% 74
2018
Q1
$38.5M Buy
+225,707
New +$41.4M 0.24% 86

Other funds holding AMGN

Mackay Shields LLC's AMGN Position: Q2 2022 in Review

Mackay Shields LLC sold out of Amgen (AMGN) in Q2 2022, closing a stake of 81,415 shares — an estimated $19.7M sold.

Mackay Shields LLC first reported a position in AMGN in Q1 2018 and held it in 16 quarters. The position peaked at $62M in Q4 2019. 2,352 funds tracked by Wall St. Rank hold AMGN as of Q2 2022.

  • Mackay Shields LLC reported no remaining Amgen position as of Q2 2022 after selling out during the quarter.
  • Mackay Shields LLC sold 81,415 Amgen shares in Q2 2022, an estimated $19.7M.
  • Mackay Shields LLC first reported a position in Amgen in Q1 2018 and held it in 16 quarters.
  • Mackay Shields LLC's Amgen position peaked at $62M in Q4 2019.
  • 2,352 funds tracked by Wall St. Rank held Amgen as of Q2 2022.

Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.